Cardiac Rehabilitation Market Size, Share, Growth Analysis, By Device(Treadmill and Heart Rate Monitor), By End user(Hospitals and Clinics, and Home Care), By Region - Industry Forecast 2024-2031

Cardiac Rehabilitation Market size was valued at USD 2.07 Billion in 2022 and is poised to grow from USD 2.17 Billion in 2023 to USD 2.23 Billion by 2031, at a CAGR of 5.1% during the forecast period (2024-2031).

The global cardiac rehabilitation market features a highly competitive landscape with a multitude of healthcare providers, medical equipment manufacturers, and technology companies vying for market share. The competitive dynamics in the industry are primarily driven by the increasing demand for cardiac rehabilitation services due to the rising prevalence of cardiovascular diseases and growing awareness about the benefits of rehabilitation programs. Additionally, advancements in medical technology and the integration of telemedicine solutions have led to the entry of new players offering innovative cardiac rehabilitation services. Established healthcare institutions, hospitals, and specialty centres are key players in providing comprehensive cardiac rehabilitation programs, leveraging their expertise, infrastructure, and experienced medical staff. Medical equipment manufacturers play a critical role by supplying devices and equipment required for exercise training and patient monitoring during rehabilitation sessions. 'Philips Healthcare (Netherlands)', 'Johnson & Johnson (USA)', 'Amer Sports Corporation (Finland)', 'Smiths Group plc (UK)', 'Core Health & Fitness, LLC (USA)', 'OMRON Corporation (Japan)', 'Life Fitness, LLC (USA)', 'McKesson Corporation (USA)', 'Technogym S.p.A. (Italy)', 'Halma plc (UK)', 'AmeriCare Medical, Inc. (USA)', 'Brunswick Corporation (USA)', 'Ball Dynamics International, LLC (USA)', 'Ossur hf (Iceland)', 'Amedtec Medizintechnik Aue GmbH (Germany)', 'Bitmos GmbH (Germany)', 'Daavlin Company (USA)', 'Drive DeVilbiss Healthcare (USA)', 'Ergoline GmbH (Germany)', 'Medical Fitness Solutions (USA)'

The rising incidence of cardiovascular diseases, including heart attacks, coronary artery disease, and heart failure, is a significant driver for the global cardiac rehabilitation market. As CVDs become a leading cause of mortality and morbidity worldwide, the demand for cardiac rehabilitation programs grows to address the rehabilitation and recovery needs of patients.

Improved Accessibility: Telemedicine allows patients to participate in cardiac rehabilitation programs from the comfort of their homes or other convenient locations. This is particularly beneficial for patients living in remote areas with limited access to specialised cardiac rehabilitation centres.

North America stands as the dominant region in the global cardiac rehabilitation market. The region's dominance can be attributed to the well-developed healthcare infrastructure, strong emphasis on preventive healthcare, and the high prevalence of CVDs in countries like the United States and Canada. Additionally, favourable reimbursement policies and increased awareness about the benefits of cardiac rehabilitation programs among healthcare providers and patients contribute to the robust adoption of these services in North America.